E. coli Protein Expression Service

CPE uses its own GMP-compliant facility for GMP protein production. A GMP facility is more than a laboratory designated for high-purity work: its design and operating procedures must support controlled material and personnel movement, appropriate segregation of processing activities, cleaning and sanitation, equipment placement and the prevention of mix-ups and cross-contamination. Closed or contained systems can reduce exposure during fermentation and transfer operations.

Cleanroom requirements are established from the process risk and the stage of manufacture. Open manipulations, transfers, post-purification handling or filling may need tighter environmental controls than well-contained fermentation processes. Where relevant, controlled areas incorporate suitable air handling or filtration, pressure relationships, gowning procedures, cleaning and environmental monitoring. The specific room classification and monitoring limits are selected for the operation; a single ISO class or EU Grade A/B/C/D cannot responsibly be assigned to every GMP E. coli production step.

If sterile final material or aseptic processing is required, the scope is assessed separately and additional sterile-manufacturing requirements may apply. GMP-grade and sterile are not interchangeable descriptions.

GMP production requires documented control over critical equipment such as bioreactors, temperature and pH sensors, mixing and aeration systems, centrifuges, homogenizers, chromatography systems and monitoring instruments. Depending on use and risk, qualification, calibration, preventive maintenance, cleaning verification or validation, and controlled utility systems help establish that equipment performs within its defined operating range. Equipment status and usage are documented as applicable.

GMP processes place greater emphasis on defined specifications and traceability for expression strains, plasmids, media components, buffers and other critical inputs. Appropriate cell substrate identification, banking or seed controls, storage conditions and records help support manufacturing consistency. Animal component-free materials may be selected for programs that require them; the quotation includes an animal component-free 2 L bioreactor production option for GMP projects.

For microbial fermentation, critical variables may include temperature, pH, dissolved oxygen, agitation, gas addition and induction conditions. Defined in-process checks, cleaning controls and segregation limit the risk of contamination. Because E. coli is a Gram-negative bacterium, endotoxin management can be important, particularly for material intended for cell-based or regulated downstream processes. Endotoxin removal, testing, acceptance limits and feasibility are established for each project; low endotoxin is not automatically equivalent to GMP status.

A GMP project is supported by a planned documentation and quality-control strategy, which may include approved procedures, material records, equipment logs, batch production records, analytical results, deviations, change management and appropriate quality review. Release tests are selected according to intended use and may include identity, purity, protein concentration, endotoxin and biological activity. Additional tests, method qualification or validation, process validation and stability studies are scoped individually rather than assumed for every quotation.